Jill Gallaher

12PUBLICATIONS
32CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Noise and wave pollution processes and measurementComputer aided designHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexity.

|Oct 17, 2025
Mathematical Oncology: How Modeling Is Transforming Clinical Decision-Making.

Kevin R Scibilia, Kit Gallagher, M A Masud

|Sep 26, 2025
Evolutionary antifragile therapy.

Jeffrey West, Bina Desai, Maximilian Strobl

|Jul 14, 2025
PSA/testosterone ratio as a potential biomarker to identify early progressors of adaptive therapy in metastatic castration sensitive prostate cancer.

Jill A Gallaher, Robert A Gatenby, Joel S Brown

|Feb 26, 2025
On the Origin of Information Dynamics in Early Life.

Robert A Gatenby, Jill Gallaher, Hemachander Subramanian

|May 19, 2023
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics.

Jill Gallaher, Maximilian Strobl, Jeffrey West

Pageof 2

Frequent Collaborators

10 joint publications

Alexander R Anderson

7 joint publications

Jeffrey West

5 joint publications

Maximilian Strobl

4 joint publications

Mark Robertson-Tessi